首页 | 本学科首页   官方微博 | 高级检索  
     


In Vitro and In Vivo Sequestration of Phencyclidine by Me4Cucurbit[8]uril**
Authors:Steven Murkli  Jared Klemm  Dr. Adam T. Brockett  Michael Shuster  Prof. Dr. Volker Briken  Prof. Dr. Matthew R. Roesch  Prof. Dr. Lyle Isaacs
Affiliation:1. Department of Chemistry and Biochemistry, University of Maryland, College Park, MD, 20742 USA;2. Department of Psychology, University of Maryland, College Park, MD, 20742 USA;3. Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742 USA
Abstract:We report investigations of the use of cucurbit[8]uril (CB[8]) macrocycles as an antidote to counteract the in vivo biological effects of phencyclidine. We investigate the binding of CB[8] and its derivative Me4CB[8] toward ten drugs of abuse ( 3 – 9 , 12 – 14 ) by a combination of 1H NMR spectroscopy and isothermal titration calorimetry in phosphate buffered water. We find that the cavity of CB[8] and Me4CB[8] are able to encapsulate the 1-amino-1-aryl-cyclohexane ring system of phencyclidine (PCP) and ketamine as well as the morphinan skeleton of morphine and hydromorphone with Kd values ≤50 nm . In vitro cytotoxicity (MTS metabolic and adenylate kinase cell death assays in HEK293 and HEPG2 cells) and in vivo maximum tolerated dose studies (Swiss Webster mice) which were performed for Me4CB[8] indicated good tolerability. The tightest host⋅guest pair (Me4CB[8]⋅PCP; Kd=2 nm ) was advanced to in vivo efficacy studies. The results of open field tests demonstrate that pretreatment of mice with Me4CB[8] prevents subsequent hyperlocomotion induction by PCP and also that treatment of animals previously dosed with PCP with Me4CB[8] significantly reduces the locomotion levels.
Keywords:cucurbituril  hyperlocomotion  molecular recognition  phencyclidine  sequestration agents
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号